Skin Cancer: Drug Gives ‘40% Melanoma Survival’

According to a new article via BBC.com, “Four-in-10 patients with a deadly skin cancer were still alive after three years when given a drug to boost their immune system, a study suggests.  The trial gave 655 patients with melanoma the drug Pembrolizumab, which...

Teva Offers EU Concessions Over Allergan Generics Deal

According to Reuters.com, “Teva Pharmaceutical Industries Ltd has offered concessions to allay EU antitrust concerns over its $40.5 billion bid for Allergan’s generics unit which will cement its position as the world’s largest generics...

Allergan and AstraZeneca Commit to Antibiotic Development Deal

According to Genengnews.com, “Dublin-based Allergan has entered into an agreement with AstraZeneca to develop and commercialize a fixed-dose antibiotic formulation currently in Phase II study. The financial terms of the agreement were not detailed, though...